Morgan Stanley Aura Biosciences, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Morgan Stanley holds 183,994 shares of AURA stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

183,994

Previous 82,840 122.11%

Holding current value

$1.51 Million

Previous $626,000 161.82%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.9 - $10.36 $697,962 - $1.05 Million	101,154 Added 122.11%	183,994 $1.64 Million
Q2 2024 Oct 17, 2024	SELL	$6.81 - $7.89 $27,348 - $31,686	-4,016 Reduced 4.62%	82,840 $626,000
Q2 2024 Aug 14, 2024	SELL	$6.81 - $7.89 $27,348 - $31,686	-4,016 Reduced 4.62%	82,840 $626,000
Q1 2024 Oct 17, 2024	BUY	$7.09 - $9.24 $28,473 - $37,107	4,016 Added 4.85%	86,856 $681,000
Q1 2024 Aug 16, 2024	BUY	$7.09 - $9.24 $28,991 - $37,782	4,089 Added 4.94%	86,856 $681,000
Q1 2024 May 15, 2024	BUY	$7.09 - $9.24 $28,991 - $37,782	4,089 Added 4.94%	86,856 $681,000
Q4 2023 Aug 16, 2024	SELL	$7.02 - $11.98 $512 - $874	-73 Reduced 0.09%	82,767 $733,000
Q4 2023 Feb 13, 2024	BUY	$7.02 - $11.98 $433,014 - $738,962	61,683 Added 292.56%	82,767 $733,000
Q3 2023 Nov 15, 2023	SELL	$8.97 - $12.38 $534,441 - $737,612	-59,581 Reduced 73.86%	21,084 $189,000
Q2 2023 Aug 14, 2023	BUY	$8.51 - $13.33 $68,692 - $107,599	8,072 Added 11.12%	80,665 $996,000
Q1 2023 May 15, 2023	BUY	$8.88 - $12.11 $70,951 - $96,758	7,990 Added 12.37%	72,593 $673,000
Q4 2022 Feb 14, 2023	BUY	$9.86 - $14.59 $93,186 - $137,890	9,451 Added 17.14%	64,603 $678,000
Q3 2022 Nov 14, 2022	BUY	$13.1 - $20.34 $8,030 - $12,468	613 Added 1.12%	55,152 $1 Million
Q2 2022 Oct 27, 2022	BUY	$12.37 - $21.86 $660,929 - $1.17 Million	53,430 Added 4817.85%	54,539 $772,000
Q2 2022 Aug 15, 2022	BUY	$12.37 - $21.86 $660,929 - $1.17 Million	53,430 Added 4817.85%	54,539 $772,000
Q1 2022 Oct 27, 2022	SELL	$15.94 - $23.34 $851,674 - $1.25 Million	-53,430 Reduced 97.97%	1,109 $24,000
Q1 2022 May 13, 2022	BUY	$15.94 - $23.34 $9,165 - $13,420	575 Added 107.68%	1,109 $24,000
Q4 2021 Feb 14, 2022	BUY	$14.76 - $24.89 $7,881 - $13,291	534 New	534 $9,000

Others Institutions Holding AURA

# of Institutions

Shares Held

37.6M

Call Options Held

122K

Put Options Held

38.5K

View Full List

About Aura Biosciences, Inc.

Ticker AURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,273,600
Market Cap $240M
Description
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...

More about AURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account